drugset / Trial / NCT03193346
BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Participants With Chronic Migraine
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study will evaluate the efficacy and safety of BOTOX® (Botulinum Toxin Type A) compared with placebo as headache prophylaxis in Chinese participants with chronic migraine.
Timeline
- Start
- 2017-07-03
- Primary completion
- 2021-03-25
- Completion
- 2021-03-25
Outcome
Outcome not reported
Stopped: “Corporation Decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 155 iu | Intramuscular |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 195 iu | Intramuscular |